Additional file 1: of Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects

Abstract

Ethical review boards that provided approval for this study. (DOC 22 kb